We have redirected you to the United States (US English) site. If you believe this is in error, you can change your selection.
Advancing Stress Urinary Incontinence Treatment
Homogenous hydrogel consisting of 97.5% water and 2.5% cross-linked polyacrylamide.1
Allows for reproducible placement of the Bulkamid cushions under direct vision.
92% of women report being cured or improved at 12 months2, with durability demonstrated at seven years3 and no serious adverse events.
In a head-to-head RCT2 evaluating Bulkamid versus TVT (tension-free vaginal tape) in 224 women with SUI, Bulkamid demonstrated excellent efficacy with no serious complications at 1 year.
An extremely low peri and postoperative complication rate in studies up to 7 years.
Author | Tooz-Hobson4 | Sokol5 | Pai6 | Andrews7 | Marthaler8 | Zivanovic9 | Freitas2 | Brosche3 |
---|---|---|---|---|---|---|---|---|
Year | 2012 | 2014 | 2015 | 2015 | 2015 | 2016 | 2020 | 2021 |
Patients | 135 | 229 | 256 | 38 | 122 | 60 | 108 | 388 |
Adverse Events | 0 (0 %) | 1 (0.4%)* | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) |
Retention | 2 (1.4 %) | 13 (5.7%) | 1 (0.4 %) | 0 (0 %) | 1 (0.8 %) | 0 (0 %) | 3 (2.8 %) | 0 (0 %) |
Infection | 0 (0 %) | 8 (3.5%) | 4 (1.6 %) | 1 (2.6 %) | 2 (1.6 %) | 2 (3.6 %) | 0 (0 %) | 11 (3.5 %) |
Follow Up | 24 Months | 12 Months | 5 Years | 6 Months | 3 Months | 12 Months | 12 Months | 7 Years |
When given the choice, 64% of women with SUI would prefer a Bulking agent for treatment of their condition10
If you feel Bulkamid may be an option for your patients, visit Bulkamid Academy to take the first step in your training journey or please contact your local representative here.